Bio-Works Technologies AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BIOWKS.ST research report →
Companywww.bio-works.com
Bio-Works Technologies AB (publ), a biotechnology company, researches, develops, manufactures, and supplies agarose-based separation products to purify proteins, peptides, and other biomolecules primarily in Sweden. It offers activated and affinity resins; BabyBio columns; immobilized metal-ion affinity chromatography resins; ion exchange resins; OptioBio glass columns; screening kits; and size exclusion chromatography resins. The company's products are used in antibodies, his-tagged proteins, proteins, peptides, oligonucleotides, and viruses and vaccines applications.
- CEO
- Lone Carlbom
- IPO
- 2017
- Employees
- 30
- HQ
- Uppsala, SE
Price Chart
Valuation
- Market Cap
- $351.00M
- P/E
- -26.24
- P/S
- 5.62
- P/B
- 8.13
- EV/EBITDA
- -19.20
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 76.48%
- Op Margin
- -28.03%
- Net Margin
- -24.39%
- ROE
- -41.90%
- ROIC
- -31.63%
Growth & Income
- Revenue
- $62.50M · 145.44%
- Net Income
- $-15,247,000 · 59.19%
- EPS
- $-0.17 · 64.58%
- Op Income
- $-17,519,000
- FCF YoY
- 55.50%
Performance & Tape
- 52W High
- $4.25
- 52W Low
- $1.45
- 50D MA
- $3.32
- 200D MA
- $2.84
- Beta
- 0.52
- Avg Volume
- 98.43K
Get TickerSpark's AI analysis on BIOWKS.ST
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our BIOWKS.ST Coverage
We haven't published any research on BIOWKS.ST yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate BIOWKS.ST Report →